angiotensin ii has been researched along with tram 34 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chia, E; Kagota, S; McGuire, JJ; Wijekoon, EP | 1 |
| Deng, XL; Li, GR; Wang, LP; Wang, Y; Zhao, LM | 1 |
2 other study(ies) available for angiotensin ii and tram 34
| Article | Year |
|---|---|
Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice.
Topics: Acetylcholine; Angiotensin II; Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Expression; In Vitro Techniques; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Oligopeptides; Pyrazoles; Receptor, PAR-2; Reverse Transcriptase Polymerase Chain Reaction; Small-Conductance Calcium-Activated Potassium Channels; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2011 |
Angiotensin II upregulates K(Ca)3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Fibroblasts; Gene Expression Regulation; Heart Ventricles; Intermediate-Conductance Calcium-Activated Potassium Channels; Losartan; Male; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Primary Cell Culture; Protein Kinase Inhibitors; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Transcription Factor AP-1; Up-Regulation; Vasoconstrictor Agents | 2013 |